# FDA Inspection 1228619 - RadMD - January 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/radmd/2581c44d-b978-47f3-aa4b-2b2fbdadf80a
Source feed: FDA_Inspections

> FDA Inspection 1228619 for RadMD on January 24, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228619
- Company Name: RadMD
- Inspection Date: 2024-01-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1215344 - 2023-08-04](https://www.keypedia.com/records/fda_inspections/radmd/aa743a9e-66da-4ef5-a2ab-10fa43a30150)
- [FDA Inspection 1136333 - 2021-02-25](https://www.keypedia.com/records/fda_inspections/radmd/60d337fe-a380-4c10-912d-56e675c5082b)

Company: https://www.keypedia.com/companies/radmd/71118c50-c84f-4c05-85fd-9db2dcb17806

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c